Yektaş, ÇiğdemCansız, Mehmet AkifTufan, Ali Evren2020-04-302020-04-3020160362-56641537-162Xhttps://doi.org/10.1097/WNF.0000000000000163https://hdl.handle.net/20.500.12684/3342Tufan, ALI EVREN/0000-0001-5207-6240; Yektas, Cigdem/0000-0002-5951-7253WOS: 000380812700011PubMed: 27332628Attention deficit hyperactivity disorder (ADHD) is among the most frequently reported coexisting psychiatric conditions in children with encopresis. Some case reports state that atomoxetine-a selective presynaptic norepinephrine reuptake inhibitor-approved for treatment of ADHD is also effective in the treatment of coexisting encopresis. Contrasting those reports, here we present a case diagnosed with ADHD and secondary encopresis without constipation whose encopretic symptoms increased after atomoxetine treatment and discuss possible mechanisms.en10.1097/WNF.0000000000000163info:eu-repo/semantics/closedAccessatomoxetineencopresisattention deficit hyperactivity disorderIncreased Frequency of Encopresis in a Child Diagnosed With Attention Deficit/Hyperactivity Disorder and Encopresis After Atomoxetine Use: A Case ReportReview Article394212213WOS:000380812700011Q3Q4